Kevin Conroy/LinkedIn
May 4, 2025, 15:06
Kevin Conroy Shares Exact Sciences’s First-Quarter 2025 Results
Kevin Conroy, Chairman and CEO at Exact Sciences, shared a post on LinkedIn:
“In Q1, the Exact Sciences team delivered over 1.2 million test results, giving over a million patients and their families the answers they need to make life-changing decisions.
We started 2025 with strong momentum in our commercial organization. In just the first few months of the year, we successfully launched the Cologuard Plus test and the Oncodetect test, two innovations that move us closer to our purpose of helping to eradicate cancer.
We also earned recognition as a Gallup Exceptional Workplace for the second year in a row – a testament to our culture of delivering results and supporting one another.
Thank you to every member of the Exact Sciences team. Your hard work is making an impact.”
Exact Sciences delivered over 1.2 million test results in Q1 2025 and launched the Cologuard Plus and Oncodetect tests. The company was also named a Gallup Exceptional Workplace for the second consecutive year.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 4, 2025, 15:06
May 4, 2025, 14:06
May 4, 2025, 13:27
May 4, 2025, 13:12